U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
South Korea Exports Hit Record High as Global Trade Momentum Builds 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
U.S. Dollar Steadies Ahead of Fed Minutes as Markets Eye Policy Divisions 
Citi Forecasts a Volatile but Ongoing Bull Market for S&P 500 in 2026 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
U.S. Stock Futures Slip as Year-End Trading Turns Cautious 
Oil Prices Stabilize at Start of 2026 as OPEC+ Policy and Geopolitical Risks Shape Market Outlook 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Singapore GDP Growth Surges in 2025 but Outlook Remains Cautious Amid Global Trade Risks 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
China Imposes 55% Tariff on Beef Imports Above Quota to Protect Domestic Industry 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
South Korean Won Slides Despite Government Efforts to Stabilize Currency Markets 
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings 
Trump Delays Tariff Increases on Furniture and Cabinets for One More Year 
Roche will be making big changes in the organization of its employees, which is estimated to be around 100,000 in number. The company is taking this step as it implements new prioritization of the works.
Announcement of change in the workforce
As part of the plans, Roche will be eliminating 300 to 400 jobs this year. The affected employees will be the ones working at the company’s product development sites.
According to Reuters, the news about job cuts was announced by Levi Garraway, the firm’s chief medical officer. Through a video call with the employees, he directly told them what the company is planning to do.
"We have made the difficult decision to reduce our workforce in PD by around five to seven percent by the end of the year," he said. "And that equates to somewhere between 300 to 400 roles that will be impacted globally."
The company knows that this is a big blow to the affected workers, so Roche will try to lessen the impact by working with employees. It was not mentioned, though, how the company intends to help those who are about to lose their position.
Who are set to lose their jobs
Based on the information shared, the Roche employees that will be cut from the company are those who are in the product development units and working in the area of project management, business management, administrative support, project delivery, managers, and posts in learning and development.
The product development sites that will cut workers are located in Canada, Britain, United States, Switzerland, and China. Those who will be laid off are set to be notified between the months of August and October, and British employees are the first ones to go.
Felix Arellano, Roche’s head of global drug safety, admitted that this is the hardest thing that he had to do since he started working for the company. He was referring to the fact that he has to send off colleagues as they have been eliminated by the company, as per Fierce Biotech.
Finally, while Roche is cutting jobs, some of the other major pharmaceutical companies are looking for more workers. Most are building new factories, so they need to hire hundreds of workers.
